|1.||Bodnar, Richard J: 1 article (12/2010)|
|2.||Lovric, Jelena: 1 article (12/2010)|
|3.||Chen, Chia-Chien: 1 article (12/2010)|
|4.||Cataldo, Giuseppe: 1 article (12/2010)|
|5.||Pytte, Carolyn L: 1 article (12/2010)|
|6.||Adams, Julye M: 1 article (02/2005)|
|7.||Legan, Sandra J: 1 article (02/2005)|
|8.||Jackson, Brian A: 1 article (02/2005)|
|9.||Ott, Cobern E: 1 article (02/2005)|
|10.||Reile, Herta: 1 article (03/2002)|
06/01/1990 - "We previously observed a significantly greater number of [3H]ER binding sites (at saturation) in nuclei of R3230AC mammary tumors from intact vs ovariectomized (ovex) rats with no difference in the affinity of [3H]ER binding for these nuclei. "
11/01/1990 - "This study identifies an early 8-week period in which hormonal changes resulting from ovex maximally stimulate the growth of liver tumors.(ABSTRACT TRUNCATED AT 400 WORDS)"
08/01/2000 - "E2 propionate suppressed angiogenesis and increased apoptosis in KPL-1 tumors, but Ovex and MPA promoted angiogenesis and decreased apoptosis. "
05/01/1997 - "Thus, the tumor promoting activity of UG, as demonstrated by increased volume fraction of liver occupied by hepatic foci in intact mice, is greatly attenuated in Ovex mice. "
11/01/1990 - "The ovex-induced increase in the number of neoplasms was spread throughout most of the size classes at both times; however, the impact on tumor burden of a small number of large tumors was only apparent at 14 weeks, when 8% of them accounted for more than two thirds of the aggregate tumor volume. "
|2.||Hypoglycemia (Reactive Hypoglycemia)
02/01/2005 - "In 17beta-estradiol (E2)-replaced OVEX rats, the hypoglycemia-induced rise in plasma EPI was reduced significantly when compared to that in vehicle-replaced OVEX rats. "
02/01/2005 - "In anesthetized female rats, insulin-induced hypoglycemia (0.25 U/kg) increased plasma EPI concentration to a significantly greater extent in 14-day ovariectomized (OVEX) rats compared to that in sham-operated controls. "
|3.||Fibrocystic Breast Disease (Chronic Cystic Mastitis)
04/01/1981 - "The incidences of cystic-type mammary dysplasia in TP rats, TP rats with E, TP rats with OVEX and E and TP rats with P were 65.5, 86.7, 91.3 and 0%, respectively."
04/01/1981 - "In TP rats with OVEX, a high incidence of mammary dysplasia was found in those given E (95.7%) but not in those given P (0%). "
04/01/1981 - "Ovariectomy (OVEX) of TP rats induced a significant and marked decrease in the incidence of mammary dysplasia (3.7%). "
10/01/1984 - "The present series of studies compared the protein compositions of estrous, diestrous, OVEX, and HYPOX vaginal discharge, and assessed whether protein digestion of estrous vaginal discharge affects its aphrodisiac activity. "
10/01/1984 - "Our previous studies have demonstrated that macromolecular fractions of hamster vaginal discharge elicit intense genital investigation and facilitate copulatory behavior toward anesthetized males (female surrogates) whose hindquarters have been scented with these fractions, and that the aphrodisiac activity is significantly reduced in the vaginal discharge of ovariectomized (OVEX) or hypophysectomized (HYPOX) females. "
10/01/1984 - "The ability of vaginal discharge from ovariectomized (OVEX) or hypophysectomized (HYPOX) female hamsters to elicit intense genital investigation and to facilitate overt copulatory behavior in males was compared with that of estrous vaginal discharge. "
10/01/1984 - "The concentration of these same proteins appear to be at least another order of magnitude lower in the vaginal discharges of OVEX and HYPOX females. "
|5.||Breast Neoplasms (Breast Cancer)
03/01/2002 - "The establishment of two new breast cancer cell lines, MXT+ and MXT-, derived from the murine breast cancer models MXT-M-3,2 MC (hormone-sensitive) and MXT-M-3,2 (ovex) MC (hormone-insensitive), is described. "
11/01/2000 - "Moreover, threo-5-PtSO4 was moderately active on the hormone- insensitive MXT-M-3.2 (Ovex) breast cancer of the mouse. "
02/01/1999 - "To clarify whether its estrogenic or its cytotoxic potency or both properties are the cause of this specific inhibitory effect, we tested meso-1-PtCl2 comparatively in vivo on an ER+ and an ER- murine breast cancer (MXT-M-3.2 MC and MXT-M-3.2(ovex) MC, respectively), and in vitro on two cell lines derived from the former in vivo models (MXT+ and MXT-, respectively). "
01/01/1991 - "A series of isomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes and cisplatin were tested on the P388 leukemia and on the murine hormone-independent MXT (M3.2) OVEX and the ovarian-hormone-dependent MXT (M3.2) mammary carcinoma for evaluating antineoplastic activity against breast cancer in vivo. "
04/01/1999 - "According to estrogen receptor (ER) and menopausal status, operable breast cancer patients were randomized for adjuvant endocrine therapy with tamoxifen (TAM) in premenopausal patients, after oophorectomy (OVEX), chemotherapy, CHEM (mitomycin C+ oral cyclophosphamide), or chemo-endocrine therapy (TAM + CHEM). "
|2.||Deoxyribonuclease I (Nickase)
|3.||salicylhydroxamic acid (SHAM)
|9.||ethylenediamine (ethylenediamine dihydroiodide)
|2.||Drug Therapy (Chemotherapy)